用户名: 密码: 验证码:
分支肽的合成与蛋白芯片的制作
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
本文采用固相合成方法人工合成了人巨细胞病毒(HCMV)抗原表位的分支多肽,并用斑点金免疫渗滤试验进行了HCMV抗体的检测。研究结果表明:
     构建了分支多肽的支架结构,采用分支状多聚赖氨酸和线形多聚赖氨酸两种,以两种不同的支架结构合成了八分支肽。
     将支架结构上的氨基酸作为合成的结合位点,按照常规方法依次进行后续氨基酸的连接,由于空间位阻效应,后续氨基酸的连接困难度增加,八分支肽中的残缺肽较多,由此方法合成的分支肽反应活性较低。
     将支架结构上的氨基酸作为合成的结合位点,将已合成并纯化好的线形肽作为待连接的短肽,连接到支架上,从而得到残缺肽极少的分支状八肽,效果较好。
     以线形多聚赖氨酸作为支架所合成的八分支肽的反应活性高于以分支状多聚赖氨酸作为支架所合成的八分支肽。
     所合成的分支多肽在蛋白芯片的硝酸纤维素膜上具有良好的结合活性和抗原活性,可用于人巨细胞病毒抗体的快速临床检测。
The author synthesized the multiple antigenic peptides with solid phase method. The MAPs were made of the human cytomlegalovirus's antigen epitope. And the DIGFA method was applied to detect the antibody against HCMV. The result shows:
    The MAPs were constructed by two kinds of scaffolding: linear lysine-tree scaffolding and branchy lysine-tree scaffolding.
    One of the synthetic methods of the MAP is to connect subsequent amino acid one by one with the lysine belonging to the lysine-tree scaffolding. Because of the steric hinderance effect, synthesis becomes more and more difficult. And for so many crippled peptides in the MAP, the reactivity of it is not so good.
    The MAP connecting pured peptide to the lysine-tree scaffolding has less crippled peptides and better reactivity.
    The MAPs linked to different lysine-tree scaffolding have different immunogenicity. The reactivity of the MAP made by linear lysine-tree scaffolding is better than the reactivity of the MAP made by branchy lysine-tree scaffolding.
    The protein chip made by coating the MAP on the nitrocellulose membrane could be developed to be a new rapid clinical detecting method because of its high binding activity and the antigenic activity of the HCMV.
引文
[1]梁宋平主编。生物化学与分子生物学实验教程。高等教育出版社,116,120页
    [2]E.Atherton,R.C.Sheppard.Solid phasepeptide synthesis. Oxford University Press, 1989,P1-3
    [3]R.B.Merrifield.Solid Phase Peptide Synthesis.I.The Synthesis of a tetrapepetide. J.Amer.Chem.Soc. 1963.85,2149
    [4]Su-Sun Wang.Solid-Phase Synthesis of Protected Peptide Hydrazides Preparation and Application of Hydroxymethyl Resin and 3-(pBenzyloxyphenyl)-1,1
    [5]B.F.Gisin and R.B.Merrifield Synthesis of a Hydrophobic Potassium Binding Peptide.Journal ojthe American Chemical Society.August 23,1972,6165
    [6]Alexander R.Mitchell,Stephen B.H.Kent,Bruce W.Erickson and R.B.Merrifield.Preparation of aminomethyl-polystyrene resin bu direct amidomethyijstion.Tetrahedron Letters. 1976.No.42,pp 3795-3798
    [7]Gui-shen Lu,l Svetlana Mojsov,James P.Tam,and R.B.Merrifield Improved Synthesis fo 4- Alkoxybenzyl Alcohol Resin J.Org.Chem.1981,46,3433-3436
    [8]Pietro G.Pietta, P.F.Cavallo,Kiyohisa Takahashi and Garland R.Marshall Preparation and Use of Benzhydrylanmine Polymers in Peptide Synthesis.Ⅱ.Syntheses of Thyrotropin Releasing Hormone,Thyrocalcitonin 26-32,and Eledoisin 1 J.org.Chem.Vol.39,No.1 1974 44-48
    [9]Les P.Mieanda and Paul F.Alewood.Accelerated chemical synthesis of peptides and small proteins Proc.Natl.Acad.Sci.USA, 1999,96,1187-1186
    [10]Lillian E.Fisher, and Donald M.Engelman.High-Yield Synthesis and Purification of an α - Helical Transmembrane Domain.Analytical Biochemistry,2001,293,102-108
    [11]Kerney Jebrell Glover,Paul M.Martini,Regitze R.Vold,and Elizabeth A.Komives.Preparation of Insoluble Transmembrane Peptides:Glycophorin-A.Prion(110- 137),and FGFR(368-397).Analytical Biochemistry, 1999,272,270-274
    [12]Irving sucholeiki.Solid-Phase Pbotocbemical C-S Bond Cteavage Of Tbioetbers-A New Approach To The Solid-Phase Produciton Of Non-Peptide Molecules.Tetrahedron Letters, 1994,Vol.35,No.40.pp.7307-7310
    [13]C.Arunan and V.N.Rajasekharan Pillai.Synthesis of Acyl Carrier Protein Fragment 65-74 on a Flexible Cross-linked Polystyrene Support: Comparison with Merrifield Resin.Tetrahedron,2000,vol56 3005-3011
    [14]Peter Sieber.A new acid-labile ancho group for the solid-phase synthesis peptide of c- terminal peptide amides bu the fmoc method. Tetrahedron Letters, 1987,vol.28.pp 2107- 2110
    [15]Paolo Rovero, Laura Quartara and Gaetano Fabbri. Synthesis of cyclic peptides on solid support. Tetrahedron Letters, 1991,Vol.32.pp 2639-2642
    
    
    [16]Margarida Gairf, Paul Lloyd-Williams,Fenando Albericio and Ernest Giralt Severe Side- Reaction in the Acidolytic Cleavage of a C-Terminal Met-containing Peptide form the Solid Support.Formation of the Homoserine Lactone Peptide.Terahedron Letters, 1994,Vol 35,pp.175-178
    [17]Wang xuebin. Preparation and applied prospect of radiopharmaceuticals labeled with 99m Tc[J]. Chin J Nucl Med, 1997, 17 (1) : 1
    [18]Harris T D, Barren J A, Bourque J P. Indium-1111-white blood cell scintigraphy in Crohn's patients with fistulae and sinus tracts[J]. J Nucl Med, 1994, 35:245
    [19]Daniel A P, John L J, William J M, et al. Thrombus imaging using technetium-99m- labeled high-potency GP Ⅱ b/Ⅲa receptor antagonists: chemistry and initial biological studies[J]. J Med Chem, 1996, 39: 1, 361
    [20]Daniel A P, John L J, William J M, et al. Somatostatin receptor-binding peptides labeled with technetium—99m: chemistry and initial biological stdies[J]. J Med Chem, 1996, 39:1361
    [21]Krenning E P, Bakker W H, Hooij P P, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison withiodine-123-Tyr-3-octreotide[J]. J Nucl Med, 1992, 33:652
    [22]Sasaki T., Kaiser E. T. J. Am. Chem. Soc. , 1989, 111, 380
    [23]宋乐新,郭子建。氨基酸、多肽的环糊精化学。无机化学学报,2001,4:457~470
    [24]Merrifield, R. B. , J. Am. Chem. Soc. , 85, 2149 (1963)
    [25]Furka, A. , Sebestyen, F. , Fsgedom, M. , and Dibo, G. , Int. J. Pept. Protein Res. , 37, 487 (1991)
    [26]Houghten, R. A. , Pinilla, C. , Blondelle, S. E. , Appel, J. R. , Dooley, C. t. and Cuervo, J. H. , Nature (London) , 354, 84 (1991)
    [27]Schuitz, P. G, Lerner, R. A, Science, 269, 1835 (1995)
    [28]ThompsonL. A. , Ellman, J. A. Chem. Rev. 555 (1996)
    [29]Szostak, J. W. , Chem, Rev. , 97. 347 (1997)
    [30]Wunsch, E. , 1974, synthese von Peptiden, Houben-Weyi, Georg Thieme, Struttgart, Bd. 15 (1&2)
    [31]Schroder, E. , and Lubke, K. , 1965, The Peptides I, Acasemic Press, New York: Schroder, E. , Lubke, K. Kloss, G. , 1975, Peptide and Proteine Ⅰ and Ⅱ, Georg Thieme, Stuttgart.
    [32]Gross, E. , and Meienhofer, J. , 1979, The Peptides, Academic Press, New York, Vol. 1; Gross, E. , and Meienhofer, J. , 1980, The Peptides, Academic
    
    Press, New York, Vol. 2; Gross, E. , and Meienhofer, J. , 1981, The Peptides, Academic Press, New York, Vol. 3;
    [33]Finn, F. M. , and Hofmann, K., 1976, The Proteins, ed. Neurath, H. , and Hill. R. L. , Academic Press, New York, Vol. Ⅱ, 105.
    [34]Jakubke, H. -D. , and Jeschkeit, H. , 1982, Aminosauren, Peptide, Protein, Veriag Chemie, Weinheim.
    [35]Blaha, K. , 1976, Amino Acids, Peptides and Related Compounds, International Review of Science, ed. Rydon, H. N. , Butterworths, London, Vo16, 73; Wade, R, 1976, Amino Acids, Peptides and Related Comounds, International Review of Science, ed. Rydon, H. N. , Butterworths, London, Vol. 6, 97; Wieland, T. , and Birr. C. , 1976, Amino Acids, Peptides and Related Compounds, International Review of Science, ed. Rydon, H. N. Butterworths, London, Vol, 6, 183
    [36]Stammer, C. H. , 1976, Amino Acids, Peptides and Related Comopounmds, MTP International Review of Science, ed. Hey, D. H. , and John, D. I. , Butterworths, Vondon, Vol. 6, 161.
    [37]Bodanszky, M. , 1984, Principles of Peptide Synthesis, Springer Verlag, Berlin; Bodanzsky, M. , and Bodanzsky, A. , 1982, The Practice of Peptide Synthesis, Springer Verlag, Berlin.
    [38]Erickson, B. W. , and Merrifield, R. B. , 1976, The Proteins, ed. Neurath, H. , and Hill, R. L. , Academic Press, New York, Vol. Ⅱ, 225; Barany, GG. , and Merrifield, T. B. , 1980, The Peptides, ed. Gross, E. , Meienhofer, J. , Academic Press, New York, Vol. 2, 1.
    [39]Birr, C. , 1978, Asspects of the Merrifield Peptide Synthesis, Springer Verlag, Berlin.
    [40]Pillai, V. N. R. , and Moutter, M. , 1982, Topics in Current Chemistry, ed. Boschke, F. L. , Springer Verlag, Berlin, 119; Atherton. E. , Logan, C. J. , and Sheppard, R. C. , 1981, J. Chem. Soc. Pekin Trans. Ⅰ, 538; Sheppard, R. C. , 1983, Chemistry in Britain 19, 402.
    [41]Mutter, M. , Hagenmaier, H, and Bayer, E. , 1971, Angew. Chemie. , 83. 883; Mutter, M. , and Bayer, E. , 1980, The Peptides, ed. Gross, E. , and Meienhofer, J. , Academic Press, New York, Vol. 2, 285.
    [42]Jakubke, H. D. , Kuhi, P. , and Konnecke, A. , 1985 Angew. Chem. , 97, 79.
    
    
    [43]Kuhl, P. , Zapevalova, N. P. , Konnecke, A. , and Jakubke, H. D. , 1983, Nonatsh. Chem. , 114, 343.
    [44]Kullmann, W. , 1982, J. Org. Chem. , 47, 5300.
    [45]Chaiken, I. M. , Komoriya, A. , Ohno, M. , and Widmer, F. , 1982, Appl. Biochem. Biotechnol. , 7, 385.
    [46]Davies, J. E. , and Gassen, H. G. , 1983, Angew, Chem. , 95, 26.
    [47]Wengenmayer, F. , 1983, Amgew. Chem. , 95, 874.
    [48]Spatola, A. F. , 1983, Chemistry and Biochemistry of Amino Acids, Peptides and Proteins, ed. Weinstein, B. , Dekker, New York, Vol. 7, 267.
    [49]Goodmann, M. , and Chorev, M. , 1981, Perspective in Peptide Chemistry, ed. Eberle, A. , Geiger, R. , and Weiland, T. , S. Karger, Basel, 283.
    [50]Schroder, E. , Rufer, C. , and Schmiechen, R. , 1982, Pharmazeutische Chemie. , Georg Thieme Verlag, Stuttgart, 468.
    [51]Vigneaud V du, Ressler C, Katsoyannis P G, J. Am. Chem. Sco. , 1953, 75, 4879; 1954, 76, 3115
    [52]Schwyzer R, and Sieber P, Nature, 1963, 199, 172
    [53]Carraway, R. , and Leeman, S. E. , 1973, J. Biol. Chem. , 248, 6854; Carraway, R. , and Leeman, S. e. , 1975, J, Biol. Chem. , 250, 1907
    [54]St-Pierre, S. , Lalonde, J. M. , Gendreau, M. Quirion, R. , Regali, D. , and Rioux, F. , 1981, J. Med. Chem. , 24, 370
    [55]Traber, R. , Loosli, H. R. , Hofmann, H, Kuhn, M. , and von Wartburg, A. , Helv. Chim, Acta, 65, 1655
    [56]Percher, T. J. , Weber, H. P. , and Ruegger, A. , 1976, Helv. Chim. Acta, 59, 1480
    [57]Wenger, R. M. , 1983, Helv, Chim. Acta, 66, 2672
    [58]Wenger, R. M. , 1984, Helv, Chim. Acta, 67, 502
    [59]龚岳亭等,生物化学与生物物理学报,1966,6,87:中国科学1965,14,1710
    [60]Kreil C, Barra D, Simmaco M Eur. J Pharmacol, 1989, 162:123
    [61]Erspamer V. Proc Natl Acad Sci, 1989, 86: 5188
    [62]嘉庆。新皮啡肽Ⅰ的固相合成及其构象研究。四川师范大学学报,2000,23(6):643~646
    [63]Brewer HB, Rittel W, Littledike T. et al. Recent studies on the chemistry of human, bovine and porcine parathyroid hormones. Amer J Medicine, 1974, 56: 759-766
    
    
    [64]Andreatta RH, Hartmann A, Johl A, et al. Synthesis of sequence 1-34 of human parathyroid hormone. Helv Chim Acta, 1973, 56: 470-473
    [65]Tregear GW, van Rietschoten J, Creene E, Solid-phase synthesis of the biologically active N-terminal 1-34 peptide of human parathyroid hormone. Hoppe Seyler Z Phylsiol Chem, 1974, 355 (4) : 415-421
    [66]周贺钺,修朝阳,陈常庆。甲状旁腺素1-34肽的固相合成。中国生化药物杂志,2002,23(3):109~111
    [67]Coy D H. Solid phase Synthesis of growth hormone release inhibiting factor[J]. Biochem, Biophys. res. Commun, 1973 (54) : 1267
    [68]Coy D H. Synthesis and biological properies of [D-Ala6, des-Gly ·NH16]LH-RH erhylamine, a peptide with greatly enhanced LH and FSH releasing activity[J]. Biochem Biophys. Res. Commun, 1974 (57) : 335.
    [69]Aremura A, [D-Ala5, des-Gly · NH10]LH-RH ethlamlne: A new analogue with unusually high LH-RH/FSH-RH activity[J]. Biochem, Biophys Res Commun, 1974 (95): 1174,
    [70]Fujino M. Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-in-ducing activity[J]. Biochem. Biophys. Res. Commun. 1974 (57) : 1248.
    [71]Mazur, R. H. Schlatter, J. M. , and Goldcamp, A. H. , 1969, J. Amer. Chem. Soc. , 91, 2684; Mazur, R. H. , Reuter, J. A. , Swiatek, K. A. , and Schlatter, J. M. , 1973, J. Med. Chem. , 16, 1284.
    [72]Otagili, K. , Miyake, I. , Ishibashi, N. , Fukui, H. , Kanehisa, H. , and Okai, H. , 1983, Bull, Chem. Soc. Jpn. , 56, 1116; tagiri, K. , Shigenaga, T. , Kanehisa, H. , and Okai, H. , 1984, Bull, Chem. Soc, Jpn. , 57, 90.
    [73]www. medinfect, com/tuition/Detail. asp?ID=43
    [74]Geyssen H M. Rodda S T, Mason T J. In synthetic peptide as antigens, ciba foundation symposium 119R[J]. Porter J Wheelan. 1986. (1) : 131-149
    [75]Emini, E. A. , Jameson, B. A. , and Wimmer, E. , 1983, Nature, 304, 699
    [76]http: //www. pharmgarden. com/dongtai/dong30. htm
    [77]孙颖,王德心,鲁桂琛。作为乙肝疫苗的新型结构肽的设计与合成。药学学报,1996,31(3):186~190
    [78]许家喜。血吸虫病合成多肽疫苗。中国寄生虫病防治杂志,1997,10(3):227~229
    
    
    [79]曹胜利,蔡孟深,石佑恩。含两种不同肽段的血吸虫多抗原肽疫苗的合成与生物活性。药学学报,1999,34(10):751~754
    [80]曹胜利,秦致辉,蔡孟深,石佑恩。血吸虫多抗原肽疫苗的合成及生物活性。药学学报,1999,34(5):368~371
    [81]曹胜利,蔡孟深,石佑恩。含两种不同肽段的血吸虫多抗原肽疫苗的合成及其对BALB/c小鼠的免疫保护作用。药学学报,2000,35(6):421~425
    [82]吴玉章,刘茂昌,贾正才,邹丽云。HBV新型免疫原的设计、合成及免疫原性研究。第三军医大学学报,2000,22(10):919~923
    [83]宋长征,赵建,韩金祥,黄海南,潘和平,梁浩。葡糖基转移酶合成肽疫苗的免疫原性研究。中华口腔医学杂志,2002,37(6):459~462
    [84]www.hairun-cc.com/hrcp/hrcp_03.html
    [85]貌判勇,洪世雯,何红霞,胡燕,汪兴太,朱传琳,楼敏,梁勇,杨建洋,鞠连才,白雁平。合成肽抗原在庚型肝炎病毒抗体检测中的初步应用。中华实验和临床病毒学杂志,1996,10(4):371~373
    [86]周文达,俞炳耀,盛婪,甄子刚,金怡,谈景婴。以合成多肽为抗原检测EB病毒抗体的酶免疫测定法。临床检验杂志,1999,17(6):330~331
    [87]杨昌生,杨英珍,陈颖,虞勇,施溥涛,陈水景页珠。应用合成肽检测病毒性心肌炎患者血清中的柯萨奇B组病毒抗体。上海医科大学学报,1999,26(2):125~128
    [88]王敏,廖玉华,郭和平。合成肽抗原检测ADP/ATP载体抗体及其在病毒性心脏病中的应用。华中医学杂志,2001,25(1):23~24
    [89]庄辉,崔怡辉,朱万孚,朱永红,徐国民。戊型肝炎病毒IgG抗体酶联免疫诊断试剂盒研制。中华预防医学杂志,2001,35(5):315~317
    [90]喻志强,王贤纯,梁宋平。虎纹捕鸟蛛毒素HWTX-Ⅰ和芋螺毒素MVIIA嵌合体的固相化学合成。湖南师范大学自然科学学报,2002,25(2):65~69
    [91]王家福,彭贤锦,谢利萍。我国南方捕鸟蛛科一新种[J]。湖南师范大学自然科学学报,1993,16(1):51~54
    [92]陈湘定,彭宽,梁宋平。虎纹捕鸟蛛毒素—Ⅰ(HWTX-Ⅰ)对豚鼠回肠的作用机制研究[J]。生命科学研究,1998,2(4):273~277
    [93]BALUS V J, NADASDI L, RAMAOBANDRAN J et al. Solution structure of ω—Conotoxin MVIIA using 2-DNMR Spectroscopy[J]. FEBS Lett, 1995, 370 (3) : 163-169
    [94]NICOLE MARTIN-MOUTOT, NATHALIE CHRISTIAN LEVEQUE, KAZUKI SATO. Interaction of snare complexes with P/Q type Calcium channels in rat cerebellar synaptosomes[J]. J Biol Chem, 1996, 271 (12) : 6567-6570
    
    
    [95]丛进阳,盖晓东,沈忠耀。用合成多肽免疫制备抗人心肌肌钙蛋白1单克隆抗体的研究。清华大学学报,1997,37(12):55~59
    [96]王振明,Tang Hong,吴轰。抗hER合成肽单克隆抗体的制备与鉴定。免疫学杂志,1997,13(4):263~265
    [97]孙瑛勋,栾晓,孙启鸿,于鸣,高亚兵,杨子义,董家新,沈倍奋。合成多肽为半抗原制备抗单克隆抗体。细胞与分子免疫学杂志,1998(2):126~128
    [98]马利民,吴文溪,管晓虹,仇镇宁。抗结直肠癌缺陷蛋白合成肽单克隆抗体的制备与初步鉴定。南京医科大学学报,2000,20(4):263~265
    [99]杨邵敏,张波,王俊梅,廖松林,韩继生,卫建平,候琳。人端粒酶hTERT抗体制备、鉴定及在肿瘤检测中的应用。中华病理学杂志,2002,31(1):50~54
    [100]Kim SK, Nielsen PE, Egholm M, et al. Right-handed triplex formed between Peptide Nucleic Acids PNA-T8 and Poly (dA) shown by linear and circular dichroism spectroscopy. J. Am. Chem. Soc. 1993, 115:6477~6481
    [101]Nielsen PE, Egholm M, Berg RH, et al. Peptide nucleic acids (PNAs) : potential antisense and antigene agents. Anticancer drug design. 1993. 8:53~63
    [102]Cohen J. Getting all turned around over the orgins of life on earth. Science. 1995, 267: 1265~1266
    [103]Fawell S, Seery J, Yasmin daikh et al. Tat-mdiated delivery of heterologous proteins into cells[J]. Proc Natl Acad Sci USA, 1994, 91: 664~668。
    [104]Elliott G. Hare P. Intercellllular trafficking and protein delivery by a herpes virus structural protein[J]. Cell, 1997, 88 (24): 223~233
    [105]Alan DF, Carl OP. Cellular uptake of the tat protein from human immunodeficiency virus[J]. Cell, 1988, 55 (23): 1189~1193
    [106]Lindgren M, Hallbrink M, Prochiantz A, et al. Cell-penetrating peptides[J]. Trends Pharmacol Sci, 2000, 21 (3): 99~103
    [107]http://www. zgxl. net/sexlore/fnkh/jxbbdgr. htm
    [108]Cope AV, Swenyp P, Sabin C, et al. Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation[J]. J Med Virol, 1997, 52:200-205
    [109]Limaye AP, Bowden RA, Myerson D, et al. Cytomegalovirus disease occurring before engraftment in marrow transplant recipient[J]. Clin Infect Dis, 1997, 24:830-835
    [110]37℃医学网
    [111]Ruellan-Eugene G, Barjot P, Campet M, et al. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus
    
    detection in amniotic fluit and maternal serum. J Med Viro, 1996, 50: 9-15.
    [112]Stagno S. In: Remington JS, Klein JO editor. Infectous diseases of the fetus and newborn infant[J]. Philadelphia; WB saunder CO. , 1995, 312~353
    [113]Ljungdahl-Stahle E, Schloss L, Sudqvist VA, et al. Solid phase ELISA for determination of the virus dose dependent sensitivity of human cytomegalovirus to antiviral drugs in vitro[J], antiviral Res, 1998, 40: 105~112
    [114]Numazaki K, Chiba S. Current aspects of diagnosis and trratment of cytomegalovirus infections in infants[J]. Clin Diagn Virol, 1997, 8:169~181
    [115]http://www. x. com. cn/yx/bing-jxb. htm
    [116]www. windrug. com
    [117]Adler SP, Hempfling SH, Starr SE et al. Pediatr Infect Dis J. 1998; 17:200-206
    [118]Anton LC, Yewdell JW, Bennink JR. J Immunol. 1997; 158:2535-2542
    [119]Faulk WP, taylor GM. An immunocolloid method for the election microscope[J]. Immunochemistry 1971, 8: 1081-1083
    [120]李永勤。以膜为固相载体的免疫胶体金快速试验。微生物学免疫学进展,2003,31(1):74~78
    [121]Hayat MA. Colloidal gold-principales, methods and applications. San Diego: Aced Press, 1989, 23, 39
    [122]肖乐义,闫小军,徐德忠,韩锋产,苏成芝,候瑜。斑点金免疫渗滤试验快速检测抗甲型肝炎病毒IgM抗体。第四军医大学学报。1996;17(6):441~443
    [123]吴健民主编。临床化学自动化免疫分析。科学出版社,38~39页,166页
    [124]Valkirs GE, et al. Immuno Concentration T M-a new format for solid-Phase immunoassay. Clim Chem 1985, 31:1427
    [125]http://www. windrug. com/book/book69. Php
    [126]马立人,蒋中华。生物芯片。化学工业出版社,2页,227~228页
    [127]Drmanac R, Labat I, Bruket I et al. Sequencing of megabase plus DNA by hybridization, Theory of the method Genomics. 1989, 4: 114~128. Yugoslav Patent Application 1987, 570.
    [128]Southern EM Analyzing polynucleotide sequences, International Patent Application 1988 PCT GB 89/00460
    [129]Southern EM Maskos U, Support bound oligonucleotides International Patent Application 1988 PCT GB 89/01114
    [130]Lipshuze RJ, Fodor SPA et al. High density synthetic oligonucleotide arrays. Nature Genetics. 1999 21(1): Suppl 20~24
    
    
    [131]Cheung VG, Morley M et al. Making and reading microarrays. Nature Genetics. 1999 21(1): Suppl 15~19
    [132]Reineke U, Volkomer-Engert R, Schneider-Mergener. Application of peptide arrays prepared by SPOT-technology. Curr Opi in Biotechnol. 2001, 12:59~64
    [133]Reineke U, Kramer A Schneider-Mergener Epitope mapping with synthetic peptides prepared by SPOT synthesis. In Antibody Engineering Springer Lab Mannual Eds Kontermann/Dueber. 2001, 433~459
    [134]Chien NH et al. Microchip system for immunoassay: an integrated immunoreactor with electrophoretic separation for serum theophylline determination. Clin Chem. 1988, 44: 591~598
    [135]赵永芳主编。生物化学技术原理及应用。科学出版社,303页
    [136]吴新刚。巨细胞病毒检测与鉴定研究进展。微生物学免疫学进展,2003,31(2):66~70
    [137]Sia I G, Patel R.New strategies for Prevention and therapy of cytomegalovirus infection and disease in solid-organ trans plant recipient[J].Clin Microbiol Rev 2000, 13 ( 1 ) : 83- 121
    [138]Lazzarotto T, Dallo CB, Campisi D, et al.Enzyme-linked Immunoadsorbent assay for the detection fo cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting.J Clin Lab Anal 1992, 6: 216-219.
    [139]Weber B, Prosser F, Munkwitz A, et al.Serological diagnosis of cytomegalovirus infection: comparison fo eight enzyme immunoassays for the detection of HCMV-specific IgM antibody.Clinical and Diagnostic Virol 1994, 2: 245-259.
    [140]Tam J P. Synthetic peptide vaccine design: synthetic and properties of a high density multiple antigenic peptide system. Proc Natl Acad Sci USA, 1988, 85:5409-5415
    [141]Posnett D N, McGrath N, Tam J P. A novel method for producing antipeptide antibodies. J Biol Chem, 1988, 263:1710-1716
    [142]孙颖,王德心,鲁桂琛。作为乙肝疫苗的新型结构肽的设计与合成。药学学报,1996,31(3):186-190
    [143]Liu Y, Qiang B, Liang z. A novel synthetic peptide vaccine: multiple antigenic peptide (MAP) .Foreigen Medical Sciences, 1991, 13 (3) : 101-102
    [144]Silvestri M, Sundqvist VA, Ruden U, Wahren B. Characterization of a major antigenic region on gp55 of human cytomegalovirus. Gen Virol. 1991 Dec; 72 ( Pt 12) : 3017-23.
    [145]蒋中华,张津辉主编。生物分子固定化技术及应用。化学工业出版社,94~98页,
    
    113页
    [146]任凌波,章思规,任晓蕾主编。生物化工产品生产工艺技术及应用。化学工业出版社,114页
    [147]Britt WJ, Vugler CG. Antiviral antibody responses in mother and newborn infants with clinical and subclinical congenital cytomegalovirus infections[J].J infect Dis, 1990, 161:214~218
    [148]Numazaki K, Chiba S. Current aspects of diagnosis and treatment of cytomegalovirus infections in infants[J].Clin Diagn Virol, 1997, 8:169~181

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700